CRDF
Cardiff Oncology Inc

18,758
Mkt Cap
$143.48M
Volume
814,407.00
52W High
$5.64
52W Low
$1.90
PE Ratio
-2.68
CRDF Fundamentals
Price
$2.13
Prev Close
$2.15
Open
$2.14
50D MA
$2.18
Beta
1.34
Avg. Volume
848,237.26
EPS (Annual)
-$0.9539
P/B
2.93
Rev/Employee
$20,696.97
Loading...
Loading...
News
all
press releases
What is HC Wainwright's Estimate for CRDF FY2025 Earnings?
Cardiff Oncology, Inc. (NASDAQ:CRDF - Free Report) - Equities researchers at HC Wainwright upped their FY2025 earnings estimates for Cardiff Oncology in a note issued to investors on Wednesday...
MarketBeat·22h ago
News Placeholder
More News
News Placeholder
Cardiff Oncology (NASDAQ:CRDF) Issues Quarterly Earnings Results
Cardiff Oncology (NASDAQ:CRDF - Get Free Report) released its earnings results on Thursday. The company reported ($0.17) earnings per share for the quarter, topping the consensus estimate of ($0.20...
MarketBeat·8d ago
News Placeholder
Cardiff Oncology (CRDF) Reports Q2 Loss, Lags Revenue Estimates
Cardiff Oncology (CRDF) delivered earnings and revenue surprises of -10.53% and -19.33%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
Cardiff Oncology (CRDF) Upgraded to Buy: Here's What You Should Know
Zacks·6mo ago
News Placeholder
Cardiff Oncology (CRDF) Reports Q1 Loss, Lags Revenue Estimates
chainwire·6mo ago
News Placeholder
Cancer Care Disruptions Highlight Growing Demand for Innovative Oncology Treatments
Cancer Care Disruptions Highlight Growing Demand for Innovative Oncology Treatments Cancer Care Disruptions Highlight Growing Demand for Innovative Oncology Treatments PR Newswire VANCOUVER, BC, Dec...
PR Newswire·11mo ago
News Placeholder
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036 Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion...
PR Newswire·2y ago
News Placeholder
Cardiff Oncology (CRDF, $5.73) Aroon Indicator entered an Uptrend on April 01, 2024.
Over the last three days, A.I.dvisor has detected that CRDF's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...
Tickeron - Stocks·2y ago
News Placeholder
Cardiff Oncology (CRDF, $5.73) entered Uptrend as Momentum indicator ascends above 0 level on Apr 01, 2024
This indicator may be signaling CRDF's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
Tickeron - Stocks·2y ago
News Placeholder
Cardiff Oncology (CRDF, $5.36) Aroon Indicator entered an Uptrend on March 28, 2024.
Over the last three days, A.I.dvisor has detected that CRDF's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...
Tickeron - Stocks·2y ago

Latest CRDF News

View

Advertisement|Remove ads.

Advertisement|Remove ads.